NSEUpdates8 Jul 2026
Panacea Biotec Limited
Updates
Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during June 2026'. The company has confirmed that no shares were dematerialized during the month of June 2026, with a total of 6,11,05,526 shares dematerialized as on June 30, 2026.
NSECertificate under SEBI (Depositories and Participants) Regulations, 20188 Jul 2026
Panacea Biotec Limited
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Panacea Biotec Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming compliance with Regulation 74(5) for the quarter ended June 30, 2026.
NSEPendency of Litigation(s)/dispute(s) or the outcome impacting the CompanyLitigation7 Jul 2026
Panacea Biotec Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
Panacea Biotec Limited has informed the Exchange about the pendency of litigation or dispute(s) or the outcome impacting the Company. The Company has received four Awards from the Presiding Officer of Industrial Tribunal, S.A.S. Nagar, Mohali, and has filed appeals against three of them in the Hon'ble High Court of Punjab and Haryana, Chandigarh.
NSETrading Window26 Jun 2026
Panacea Biotec Limited
Trading Window
Panacea Biotec Limited has informed the Exchange regarding the closure of the trading window for its designated persons due to the upcoming unaudited financial results for the quarter ending June 30, 2026.